419 related articles for article (PubMed ID: 18068383)
21. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
Johnston IN; Westbrook RF
Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
[TBL] [Abstract][Full Text] [Related]
23. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
[TBL] [Abstract][Full Text] [Related]
25. Effects of ketamine on acute somatic nociception in wild-type and N-methyl-D-aspartate (NMDA) receptor epsilon1 subunit knockout mice.
Petrenko AB; Yamakura T; Askalany AR; Kohno T; Sakimura K; Baba H
Neuropharmacology; 2006 May; 50(6):741-7. PubMed ID: 16427663
[TBL] [Abstract][Full Text] [Related]
26. Spinal antinociceptive effects of AA501, a novel chimeric peptide with opioid receptor agonist and tachykinin receptor antagonist moieties.
Bonney IM; Foran SE; Marchand JE; Lipkowski AW; Carr DB
Eur J Pharmacol; 2004 Mar; 488(1-3):91-9. PubMed ID: 15044040
[TBL] [Abstract][Full Text] [Related]
27. Effect of glutamic acid and ketamine on morphine-induced analgesic response in rats.
Suman P; Talwar A; Tandon OP
Indian J Physiol Pharmacol; 2000 Jan; 44(1):33-42. PubMed ID: 10919093
[TBL] [Abstract][Full Text] [Related]
28. Antinociceptive effect and interaction of uncompetitive and competitive NMDA receptor antagonists upon capsaicin and paw pressure testing in normal and monoarthritic rats.
Pelissier T; Infante C; Constandil L; Espinosa J; Lapeyra CD; Hernández A
Pain; 2008 Jan; 134(1-2):113-27. PubMed ID: 17517475
[TBL] [Abstract][Full Text] [Related]
29. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
Ossipov MH; Harris S; Lloyd P; Messineo E
J Pharmacol Exp Ther; 1990 Dec; 255(3):1107-16. PubMed ID: 2262895
[TBL] [Abstract][Full Text] [Related]
30. Buprenorphine-induced hyperalgesia in the rat.
Wala EP; Holtman JR
Eur J Pharmacol; 2011 Jan; 651(1-3):89-95. PubMed ID: 21114985
[TBL] [Abstract][Full Text] [Related]
31. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
[TBL] [Abstract][Full Text] [Related]
32. Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker.
Mollica A; Costante R; Stefanucci A; Pinnen F; Lucente G; Fidanza S; Pieretti S
J Pept Sci; 2013 Apr; 19(4):233-9. PubMed ID: 23136069
[TBL] [Abstract][Full Text] [Related]
33. Role of glutamatergic receptors located in the nucleus raphe magnus on antinociceptive effect of morphine microinjected into the nucleus cuneiformis of rat.
Haghparast A; Soltani-Hekmat A; Khani A; Komaki A
Neurosci Lett; 2007 Oct; 427(1):44-9. PubMed ID: 17920194
[TBL] [Abstract][Full Text] [Related]
34. [Dextromethorphan enhances analgesic activity of propacetamol--experimental study].
Dobrogowski J; Wordliczek J; Przewłocka B
Folia Med Cracov; 2005; 46(1-2):99-119. PubMed ID: 17037292
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats.
Plesan A; Hedman U; Xu XJ; Wiesenfeld-Hallin Z
Anesth Analg; 1998 Apr; 86(4):825-9. PubMed ID: 9539609
[TBL] [Abstract][Full Text] [Related]
36. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
37. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
38. The analgesic activity of biphalin and its analog AM 94 in rats.
Leone S; Chiavaroli A; Orlando G; Mollica A; Di Nisio C; Brunetti L; Vacca M
Eur J Pharmacol; 2012 Jun; 685(1-3):70-3. PubMed ID: 22546229
[TBL] [Abstract][Full Text] [Related]
39. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
[TBL] [Abstract][Full Text] [Related]
40. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.
Hua XY; Hayes CS; Hofer A; Fitzsimmons B; Kilk K; Langel U; Bartfai T; Yaksh TL
J Pharmacol Exp Ther; 2004 Feb; 308(2):574-82. PubMed ID: 14610237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
